2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
84
Prostatic Neoplasms
73
Leukemia, Myeloid, Acute
73
Carcinoma, Non-Small-Cell Lung
61
Neoplasm Metastasis
60
Breast Neoplasms
56
Multiple Myeloma
47
Colorectal Neoplasms
47
Pancreatic Neoplasms
43
Carcinoma, Renal Cell
36
Myelodysplastic Syndromes
35
Melanoma
35
Ovarian Neoplasms
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Triple Negative Breast Neoplasms
28
Glioblastoma
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, Large B-Cell, Diffuse
26
Urinary Bladder Neoplasms
25
Lymphoma
23
Squamous Cell Carcinoma of Head and Neck
22
Burkitt Lymphoma
22
Fallopian Tube Neoplasms
21
Glioma
20
Carcinoma, Hepatocellular
20
Brain Neoplasms
18
Mouth Neoplasms
17
Lymphoma, Non-Hodgkin
17
Leukemia, Biphenotypic, Acute
17
Endometrial Neoplasms
17
Interventions
Cisplatin
57
Pemetrexed
46
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
Drug Therapy
9
atezolizumab
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Specimen Handling
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled